Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Iulian Dragan

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Diabetologia|February 20, 2024
An omics-based machine learning approach to predict diabetes progression: a RHAPSODY studyRoderick C Slieker, Magnus Münch, Louise A Donnelly, et al.
Frontiers in Endocrinology|March 21, 2024
Multi-omics subgroups associated with glycaemic deterioration in type 2 diabetes: an IMI-RHAPSODY StudyShiying Li, Iulian Dragan, Van Du T Tran, et al.
Diabetologia|June 10, 2021
Replication and cross-validation of type 2 diabetes subtypes based on clinical variables: an IMI-RHAPSODY studyRoderick C Slieker, Louise A Donnelly, Hugo Fitipaldi, et al.
Diabetes|August 11, 2021
Distinct Molecular Signatures of Clinical Clusters in People With Type 2 Diabetes: An IMI-RHAPSODY StudyRoderick C Slieker, Louise A Donnelly, Hugo Fitipaldi, et al.
Life (Basel, Switzerland)|February 24, 2024
A Federated Database for Obesity Research: An IMI-SOPHIA StudyCarl Delfin, Iulian Dragan, Dmitry Kuznetsov, et al.
Nature Communications|May 3, 2023
Identification of biomarkers for glycaemic deterioration in type 2 diabetesRoderick C Slieker, Louise A Donnelly, Elina Akalestou, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Diabetologia|February 20, 2024
An omics-based machine learning approach to predict diabetes progression: a RHAPSODY studyRoderick C Slieker, Magnus Münch, Louise A Donnelly, et al.
Frontiers in Endocrinology|March 21, 2024
Multi-omics subgroups associated with glycaemic deterioration in type 2 diabetes: an IMI-RHAPSODY StudyShiying Li, Iulian Dragan, Van Du T Tran, et al.
Diabetologia|June 10, 2021
Replication and cross-validation of type 2 diabetes subtypes based on clinical variables: an IMI-RHAPSODY studyRoderick C Slieker, Louise A Donnelly, Hugo Fitipaldi, et al.
Diabetes|August 11, 2021
Distinct Molecular Signatures of Clinical Clusters in People With Type 2 Diabetes: An IMI-RHAPSODY StudyRoderick C Slieker, Louise A Donnelly, Hugo Fitipaldi, et al.
Life (Basel, Switzerland)|February 24, 2024
A Federated Database for Obesity Research: An IMI-SOPHIA StudyCarl Delfin, Iulian Dragan, Dmitry Kuznetsov, et al.
Nature Communications|May 3, 2023
Identification of biomarkers for glycaemic deterioration in type 2 diabetesRoderick C Slieker, Louise A Donnelly, Elina Akalestou, et al.
Pageof 1